Metlife’s Neutral Rating Reaffirmed at Zacks (MET)
Metlife (NYSE:MET)‘s stock had its “neutral” rating restated by Zacks in a research report issued to clients and investors on Tuesday. They currently have a $58.00 price target on the stock. Zacks‘s price target would indicate a potential upside of 7.23% from the company’s current price.
A number of other firms have also recently commented on MET. Analysts at Sterne Agee reiterated a “buy” rating on shares of Metlife in a research note on Thursday, July 17th. They now have a $66.00 price target on the stock, up previously from $65.00. Separately, analysts at Deutsche Bank reiterated a “buy” rating on shares of Metlife in a research note on Monday, July 14th. They now have a $67.00 price target on the stock, up previously from $61.00. Finally, analysts at Citigroup Inc. reiterated a “buy” rating on shares of Metlife in a research note on Wednesday, July 9th. They now have a $64.00 price target on the stock, up previously from $62.00. Three analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company. Metlife currently has an average rating of “Buy” and a consensus target price of $61.00.
Metlife (NYSE:MET) traded down 1.31% on Tuesday, hitting $54.09. 5,276,159 shares of the company’s stock traded hands. Metlife has a one year low of $45.52 and a one year high of $57.57. The stock’s 50-day moving average is $55.66 and its 200-day moving average is $52.48. The company has a market cap of $60.882 billion and a P/E ratio of 17.18. Metlife also was the recipient of a significant decrease in short interest in July. As of July 15th, there was short interest totalling 21,587,224 shares, a decrease of 13.6% from the June 30th total of 24,979,043 shares. Based on an average daily volume of 4,705,426 shares, the days-to-cover ratio is presently 4.6 days. Approximately 2.3% of the company’s stock are sold short.
Metlife (NYSE:MET) last posted its quarterly earnings results on Wednesday, April 30th. The company reported $1.37 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.40 by $0.03. Analysts expect that Metlife will post $5.67 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, September 12th. Shareholders of record on Friday, August 8th will be given a dividend of $0.35 per share. This represents a $1.40 dividend on an annualized basis and a yield of 2.59%. The ex-dividend date of this dividend is Wednesday, August 6th.
MetLife, Inc (NYSE:MET) is a provider of insurance, annuities and employee benefit programs, serving 90 million customers in over 50 countries.
To view Zacks’ full report, visit Zacks’ official website.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.